-30%

est. 2Y upside i

HealthcareSeries C

Rank

#2965

Sector

Digital Health

Est. Liquidity

~3Y

Data Quality

Data: Low

This analysis is highly uncertain due to missing financial data.

Last updated: July 3, 2026

Bull (15%)+50%

Uncertain due to missing data. If Cleo has grown revenue significantly (e.g., >40% YoY) and IPO window opens, equity could appreciate strongly. Notable customers (Salesforce, PepsiCo) and low capital intensity support potential.

Base (55%)-20%

Cannot compute precisely due to missing revenue and valuation. Stale Series C from 2021 suggests flat or moderate growth; high incumbent threat from Maven and Carrot limits upside. Expect modest dilution and preference overhang.

Bear (30%)-100%

If company fails to raise capital or loses competitive battle, common equity is worthless. Total funding of $86.9M creates large preference stack; any exit below that wipes out common.

Est. time to liquidity~3.0 years

Preference Stack Risk

high

Funding Intensity

0%

Total funding of $86.9M likely exceeds or is a large portion of current valuation, leading to significant preference overhang for common stock.

Dilution Risk

high

No funding in 5+ years suggests a raise is imminent, likely at a down or flat round, diluting existing holders.

Secondary Liquidity

none

No secondary trading reported; liquidity for employee equity is uncertain.

Other 8 roles

View all 8 open roles at Cleo

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Cleo's data — designed to show you've done your homework.

  • 1

    What is Cleo's current annual recurring revenue (ARR) and growth rate?

  • 2

    How does Cleo differentiate from Maven Clinic and Carrot Fertility in terms of employer adoption?

  • 3

    What is the expected timeline for an IPO or acquisition, and what is the current common stock valuation?

Community

Valuation Sentiment

Our model estimates -30% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.